| Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better? S Kourakis, CA Timpani, DG Campelj, P Hafner, N Gueven, D Fischer, ... Orphanet Journal of Rare Diseases 16, 1-9, 2021 | 62 | 2021 |
| The failed clinical story of myostatin inhibitors against Duchenne muscular dystrophy: exploring the biology behind the battle E Rybalka, CA Timpani, DA Debruin, RM Bagaric, DG Campelj, A Hayes Cells 9 (12), 2657, 2020 | 49 | 2020 |
| BGP-15 protects against oxaliplatin-induced skeletal myopathy and mitochondrial reactive oxygen species production in mice JC Sorensen, AC Petersen, CA Timpani, DG Campelj, J Cook, AJ Trewin, ... Frontiers in pharmacology 8, 137, 2017 | 44 | 2017 |
| Chemotherapy-induced myopathy: the dark side of the cachexia sphere DG Campelj, CA Goodman, E Rybalka Cancers 13 (14), 3615, 2021 | 35 | 2021 |
| Irinotecan-induced gastrointestinal dysfunction is associated with enteric neuropathy, but increased numbers of cholinergic myenteric neurons RM McQuade, V Stojanovska, EL Donald, AA Rahman, DG Campelj, ... Frontiers in physiology 8, 391, 2017 | 22 | 2017 |
| The regulation of polyamine pathway proteins in models of skeletal muscle hypertrophy and atrophy: A potential role for mTORC1 M Tabbaa, T Ruz Gomez, DG Campelj, P Gregorevic, A Hayes, ... American Journal of Physiology-Cell Physiology 320 (6), C987-C999, 2021 | 19 | 2021 |
| The paradoxical effect of PARP inhibitor BGP-15 on irinotecan-induced cachexia and skeletal muscle dysfunction DG Campelj, CA Timpani, AC Petersen, A Hayes, CA Goodman, ... Cancers 12 (12), 3810, 2020 | 10 | 2020 |
| Metronomic 5-Fluorouracil delivery primes skeletal muscle for myopathy but does not cause cachexia DG Campelj, CA Timpani, T Cree, AC Petersen, A Hayes, CA Goodman, ... Pharmaceuticals 14 (5), 478, 2021 | 8 | 2021 |
| Adenylosuccinic acid: A novel inducer of the cytoprotectant Nrf2 with efficacy in Duchenne muscular dystrophy E Rybalka, CA Goodman, DG Campelj, A Hayes, CA Timpani Current Medical Research and Opinion 37 (3), 465-467, 2021 | 7 | 2021 |
| Sodium nitrate co-supplementation does not exacerbate low dose metronomic doxorubicin-induced cachexia in healthy mice DG Campelj, DA Debruin, CA Timpani, A Hayes, CA Goodman, ... Scientific Reports 10 (1), 15044, 2020 | 6 | 2020 |
| NAD+ Therapeutics and Skeletal Muscle Adaptation to Exercise in Humans D Campelj, A Philp Sports Medicine 52 (Suppl 1), 91-99, 2022 | 5 | 2022 |
| Transient changes to metabolic homeostasis initiate mitochondrial adaptation to endurance exercise JR Dent, B Stocks, DG Campelj, A Philp Seminars in Cell & Developmental Biology 143, 3-16, 2023 | 4 | 2023 |
| Cachectic muscle wasting in acute myeloid leukaemia: a sleeping giant with dire clinical consequences DG Campelj, CA Timpani, E Rybalka Journal of Cachexia, Sarcopenia and Muscle 13 (1), 42-54, 2022 | 4 | 2022 |
| Dimethyl fumarate modulates the dystrophic disease program following short-term treatment CA Timpani, S Kourakis, DA Debruin, DG Campelj, N Pompeani, ... JCI insight 8 (21), 2023 | 3 | 2023 |
| Dimethyl fumarate modulates the Duchenne muscular dystrophy disease program following short-term treatment in mdx mice CA Timpani, S Kourakis, DA Debruin, DG Campelj, N Pompeani, ... bioRxiv, 2022.09. 15.508124, 2022 | 2 | 2022 |
| Idebenone protects against chemotherapy-induced skeletal muscle wasting and mitochondrial dysfunction in mice J Sorensen, C Timpani, D Campelj, A Petersen, A Hayes, E Rybalka Proceedings of the Australian Physiological Society 46, 2015 | 2 | 2015 |
| Combined orchiectomy and limb immobilization recapitulate early age‐related changes to skeletal muscle in mice DA Debruin, J Murphy, DG Campelj, R Bagaric, CA Timpani, ... JCSM Communications, 2024 | | 2024 |
| Unravelling the mechanisms of chemotherapy-induced cachexia and the potential of mitoprotective therapeutic strategies DG Campelj Victoria University, 2021 | | 2021 |
